GPT and Hepatic fibrosis: In this clinically relevant model, CCl4 treatment for 4 weeks induced liver fibrosis, as indicated by serum parameters of hepatocyte damage (ALT and AST levels) and histological indicators, whereas the concomitant administration of Asp significantly inhibited hepatocyte damage.